{"id":"W2519988759","doi":"10.2196/resprot.5872","title":"EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia","year":2016,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"International Fund for Agricultural Development; United Nations High Commissioner for Refugees; United Nations Development Programme; National Heart, Lung, and Blood Institute; Pan American Health Organization; International Labour Organization; United Nations Population Fund; International Atomic Energy Agency; UNICEF; United Nations Educational, Scientific and Cultural Organization","keywords":"Medicine; Open label; Disease; Clinical trial; Anemia; Sickle cell anemia; Pediatrics; Intensive care medicine; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001929286,0.0002899098,0.0007628914,0.0002245278,0.0002793106,0.0000520896,0.0003684149,0.0002747217,0.0001180137],"category_scores_gemma":[0.0007485268,0.0001565684,0.0001653796,0.0003073172,0.0003538565,0.0001862151,0.0002417781,0.0003092909,0.00001442447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002800262,"about_ca_system_score_gemma":0.0008366582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006093339,"about_ca_topic_score_gemma":0.00001300131,"domain_scores_codex":[0.9960164,0.0007975652,0.0009804997,0.0008237596,0.0005133285,0.0008684833],"domain_scores_gemma":[0.9972186,0.0008877029,0.0001908661,0.000752834,0.0001698281,0.0007801655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.495617,0.1249528,0.005128292,0.000366537,0.00005621551,0.0006231511,0.0003923494,0.000002633634,0.01532851,0.0002255058,0.0008022131,0.3565048],"study_design_scores_gemma":[0.6426711,0.3071901,0.0005380674,0.001135644,0.00003511325,0.000005502487,0.0001127903,0.0005552571,0.002848957,0.0005249423,0.04413304,0.0002494878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.5696982,0.0000116137,0.00001797292,0.0009209619,0.00001531013,0.4283479,0.00004870095,0.00003639717,0.0009029387],"genre_scores_gemma":[0.2635799,0.00003125929,0.0003783205,0.00003985606,0.0002252003,0.7333494,0.0000341636,0.00004230603,0.002319617],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.3562553,"threshold_uncertainty_score":0.6384673,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4767839617624962,"score_gpt":0.6143123563726977,"score_spread":0.1375283946102014,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}